Proximity Assay for Factor D Activity Measurement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring Factor D activity and determining the potency of Factor D inhibitors are complex, time-consuming, and not adaptable to high-throughput assays, limiting their effectiveness in diagnosing disorders and assessing therapeutic efficacy.
Innovation Solution
A proximity-based measurement assay that measures the cleavage of Factor B using labeled antibodies and moieties, allowing for simple, fast, and homogeneous analysis of Factor D activity and inhibitor potency, which can be scaled for high-throughput screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods for measuring Factor D activity are used, then measurement can be performed, but the process becomes complex and time-consuming
Solution Approach 1:
The assay is segmented into distinct functional components: Factor B substrate with C3b binding domain, detection antibodies specific to Factor B cleavage products, and signal generation system. This segmentation allows each component to be optimized independently while simplifying the overall measurement process.
Solution Approach 2:
Detection antibodies serve as intermediaries that bridge the enzymatic cleavage event and the measurable signal. These antibodies specifically bind to cleavage products and generate detectable signals, simplifying the measurement process while maintaining precision.
2Measurement precision
If traditional methods for measuring Factor D activity are used, then measurement can be performed, but the process is time-consuming
Solution Approach 1:
Factor B is pre-incubated with C3b binding domain and detection antibodies before adding Factor D enzyme. This preliminary setup allows the assay to proceed directly to measurement upon enzyme addition, reducing total assay time while maintaining measurement precision.
Solution Approach 2:
The assay is designed as a continuous homogeneous reaction where Factor D continuously cleaves Factor B and detection antibodies continuously generate signals. This eliminates stopping and starting steps, reducing assay time while maintaining precision through continuous measurement.
3Measurement precision
If traditional methods for measuring Factor D activity are used, then measurement can be performed, but they are not adaptable to high-throughput assays
Solution Approach 1:
The assay components are designed with universal characteristics: Factor B substrate can be used with different detection antibodies, and the signal generation system is compatible with multiple detection platforms. This universality enables the same basic assay to be adapted to high-throughput formats while maintaining measurement precision.
Solution Approach 2:
The assay parameters such as component concentrations, incubation times, and signal detection settings can be adjusted to optimize for high-throughput formats. This flexibility allows the same assay design to maintain precision across different throughput levels.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides precise and efficient measurement of Factor D activity and inhibitor potency, facilitating diagnostics and therapeutic assessment, and enabling rapid screening of Factor D inhibitors.
Implementation Method 1
measuring the cleavage of Factor B using a proximity-based measurement assay
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to methods of measuring the activity of Factor D, the key driver in the activation of the alternative complement pathway, methods of determining the potency of Factor D inhibitors, and methods of screening for Factor D inhibitors.